academic.oup.com Open in urlscan Pro
52.224.90.245  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to Main Content
Advertisement
Journals
Books
 * Search Menu
 * 
 * 
 * Menu
 * 
 * 
 * Sign in through your institution


Navbar Search Filter Open Forum Infectious DiseasesIDSA Journals Infectious
DiseasesBooksJournalsOxford Academic Mobile Enter search term Search
 * Issues
   * Volume 11, Issue 11, November 2024 (In Progress)
   * Volume 11, Issue 10, October 2024
   * Browse all
 * More Content
   * Advance articles
   * Editor's Choice
   * Insight Articles
   * Novel ID Cases and Teaching Cases
   * Podcasts
   * Supplement Archive
   * Cover Archive
   * IDSA Journals
   * Clinical Infectious Diseases
   * The Journal of Infectious Diseases
 * Publish
   * Author Guidelines
   * Submit
   * Open Access
   * Why Publish
   * IDSA Journals Calls for Papers
 * Alerts
 * About
   * About Open Forum Infectious Diseases
   * About the Infectious Diseases Society of America
   * About the HIV Medicine Association
   * IDSA COI Policy
   * Editorial Board
   * Advertising and Corporate Services
   * Journals Career Network
   * Self-Archiving Policy
   * For Reviewers
   * For Press Offices
 * Journals on Oxford Academic
 * Books on Oxford Academic

IDSA Journals





 * Issues
   * Volume 11, Issue 11, November 2024 (In Progress)
   * Volume 11, Issue 10, October 2024
   * Browse all
 * More Content
   * Advance articles
   * Editor's Choice
   * Insight Articles
   * Novel ID Cases and Teaching Cases
   * Podcasts
   * Supplement Archive
   * Cover Archive
   * IDSA Journals
   * Clinical Infectious Diseases
   * The Journal of Infectious Diseases
 * Publish
   * Author Guidelines
   * Submit
   * Open Access
   * Why Publish
   * IDSA Journals Calls for Papers
 * Alerts
 * About
   * About Open Forum Infectious Diseases
   * About the Infectious Diseases Society of America
   * About the HIV Medicine Association
   * IDSA COI Policy
   * Editorial Board
   * Advertising and Corporate Services
   * Journals Career Network
   * Self-Archiving Policy
   * For Reviewers
   * For Press Offices

Close
Navbar Search Filter Open Forum Infectious DiseasesIDSA Journals Infectious
DiseasesBooksJournalsOxford Academic Enter search term Search
Advanced Search
Search Menu

Latest Issue
Volume 11 Issue 11
November 2024


EDITOR'S CHOICE

Gut microbiome in human melioidosis: composition and resistome dynamics from
diagnosis to discovery
Soumi Chowdhury and others
The first study in the Indian melioidosis cohort, shows persistent gut
microbiome and resistome disruptions post-melioidosis, with pathogenic bacteria,
depleted butyrate-producers, and high antimicrobial resistance, even six months
post-infection, preceding secondary Klebsiella pneumoniae infections.


LATEST ARTICLES

Gut microbiome in human melioidosis: composition and resistome dynamics from
diagnosis to discovery
Soumi Chowdhury and others
The first study in the Indian melioidosis cohort, shows persistent gut
microbiome and resistome disruptions post-melioidosis, with pathogenic bacteria,
depleted butyrate-producers, and high antimicrobial resistance, even six months
post-infection, preceding secondary Klebsiella pneumoniae infections.
The Impact of the U.S. Maternal Tdap Vaccination Program on Preventing Pertussis
in Infants 2-<6 Months of Age: A Case-control Evaluation
Tami H Skoff and others
Background To protect infants aged <2 months against pertussis, the United
States recommends Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular
pertussis) vaccination during each pregnancy. Data are limited on the strategy’s
effectiveness against pertussis in infants aged ≥2 months. Methods Pertussis
cases ...
Prescribing Patterns of High Opioid and Antibiotic Prescribers, Washington
State, 2021: Do some prescribers have trouble saying no?
David Trey Evans and others
Among Washington State emergency and family medicine physicians, high
prescribers of opioids were 2.9 times more likely to be high prescribers of
antibiotics in the Medicare Part D population. The inverse relationship showed
the same association. Antimicrobial and opioid stewards should collaborate on
shared goals to ...
Breakthrough Rectal Neisseria gonorrhoeae Infections After Meningococcal B
Vaccination: Microbiological and Clinical Features
Angelo Roberto Raccagni and others
Breakthrough rectal Neisseria gonorrhoeae infections following 4CMenB
vaccination among gay, bisexual, and other men who have sex with men were
preferentially identified in people with higher-risk sexual behaviors, were less
often symptomatic and more often associated with negative gonococcal-specific
culture.
Lack of Detection of Norwalk Virus in Saliva Samples from a Controlled Human
Infection Model
Robert L Atmar and others
Following recent reports of norovirus replication in salivary gland cells, we
examined whether the prototype norovirus strain, Norwalk virus (GI.1), could be
detected in the saliva of 21 experimentally-infected persons. Viral RNA was not
detected in saliva 2 and 7 days after challenge despite high levels being
present in ...


EDITOR'S CHOICE

Gut microbiome in human melioidosis: composition and resistome dynamics from
diagnosis to discovery
Soumi Chowdhury and others
The first study in the Indian melioidosis cohort, shows persistent gut
microbiome and resistome disruptions post-melioidosis, with pathogenic bacteria,
depleted butyrate-producers, and high antimicrobial resistance, even six months
post-infection, preceding secondary Klebsiella pneumoniae infections.
4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results from a
Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young
Adults
Terry Nolan and others
Background Meningococcal serogroup B (MenB) strains are highly diverse. Breadth
of immune response for the MenB vaccine, 4CMenB, administered at 0-2, 0-6, or
0-2-6 months, was demonstrated by endogenous complement-human serum bactericidal
antibody (enc-hSBA) assay against an ...
A Comparison of Different Strategies for Optimizing the Selection of Empiric
Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive
Care Units (ICUs): Unit-Specific Combination Antibiograms Versus
Patient-Specific Risk Factors
Walaiporn Wangchinda and others
Both unit-specific combination antibiograms and patient-specific factors help
improve the appropriateness of empiric antibiotic selection for ICU pneumonia.
However, the patient-specific risk factor approach is comparatively more
effective, leading to higher rates of appropriate therapy and less antibiotic
overuse.
CAF to the rescue! Potential and challenges of combination antifungal therapy
for reducing morbidity and mortality in hospitalized patients with serious
fungal infections
Samantha E Jacobs and Vishnu Chaturvedi
Combination antifungal therapy (CAF) for invasive fungal diseases could improve
patient outcomes. Prioritization of future clinical trials of CAF should be
based upon animal models showing improved survival, observational clinical data
demonstrating efficacy and safety, and antifungal combination testing.
Advertisement
Read now



EMERGING RESEARCH IN CLINICAL MYCOLOGY SPECIAL COLLECTION

Browse a special collection of articles from Open Forum Infectious Diseases on
'Emerging Research in Clinical Mycology'. Articles in the collection were
submitted following a call for proposals from the journal in 2023.

Read now


Tweets by @OFIDJournal


 * MOST READ


 * MOST CITED

Beyond Human Babesiosis: Prevalence and Association of Babesia Coinfection with
Mortality in the United States, 2015–2022: A Retrospective Cohort Study

Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine

Short Versus Long Antibiotic Duration in Streptococcus pneumoniae Bacteremia

A Retrospective Assessment of Guideline Adherence and Treatment Outcomes From
Clostridioides difficile Infection Following the IDSA 2021 Clinical Guideline
Update: Clostridioides difficile Infection

Concurrent Administration of COVID-19 and Influenza Vaccines Enhances
Spike-Specific Antibody Responses




OFID WELCOMES EDITORIAL MENTEE

After a successful pilot program last year, the IDSA journals are pleased to
announce the mentees participating in the 2024 editorial mentoring program.
Jodian Pinkney, MBBS, DM, from Massachusetts General Hospital and Harvard
Medical School will be serving as OFID’s editorial mentee. Dr. Pinkney will work
directly with OFID editors through January 2025 to gain a deeper understanding
of a medical journal editor’s role and work. Our editors are grateful to all who
applied and look forward to working with Dr. Pinkney.

OFID Now Offers Review Pathway for Papers Rejected by High-Impact Journals



OFID NOW OFFERS REVIEW PATHWAY FOR PAPERS REJECTED BY HIGH-IMPACT JOURNALS

Open Forum Infectious Diseases welcomes papers that have been peer reviewed by
another medical journal and were not accepted for publication, where the authors
believe they can address the essential concerns identified by previous
reviewers. Under this new pathway, authors can revise the paper according to the
review comments they previously received and then submit the paper to OFID. This
new pathway is intended to speed publication and minimize unnecessary re-review
of papers that previously received thorough and detailed review elsewhere.

Learn more about how to submit using this pathway.

SUPPLEMENTS AND INSIGHT ARTICLES

 * Mpox Outbreak 2022 and Beyond: Understanding Transmission to Inform Public
   Health Responses
 * The Enterics for Global Health (EFGH) Shigella Surveillance Study-Rationale
   and Methods
 * IDWeek 2023 Abstracts

Supplement Archive


STAY CONNECTED

The IDSA Journals app gives you the freedom to read Open Forum Infectious
Diseases both online and offline, on your iPad, iPhone, or iPod Touch.

Register for email alerts and get notified as soon as new issues are published
online.


RELATED TITLES

Clinical Infectious Diseases The Journal of Infectious Diseases Journal of
Travel Medicine Journal of the Pediatric Infectious Diseases Society Oxford Open
Immunology Clinical and Experimental Immunology Immunotherapy Advances Discovery
Immunology Journal of Applied Microbiology Letters in Applied Microbiology

Advertisement
close advertisement
Advertisement
 * About Open Forum Infectious Diseases
 * Editorial Board
 * Author Guidelines
 * Facebook
 * X (formerly Twitter)

 * Advertising and Corporate Services
 * Journals Career Network


 * Online ISSN 2328-8957
 * Copyright © 2024 Infectious Diseases Society of America

 * About Oxford Academic
 * Publish journals with us
 * University press partners
 * What we publish
 * New features 

 * Authoring
 * Open access
 * Purchasing
 * Institutional account management
 * Rights and permissions

 * Get help with access
 * Accessibility
 * Contact us
 * Advertising
 * Media enquiries

 * Oxford University Press
 * News
 * Oxford Languages
 * University of Oxford

Oxford University Press is a department of the University of Oxford. It furthers
the University's objective of excellence in research, scholarship, and education
by publishing worldwide

 * Copyright © 2024 Oxford University Press
 * Cookie settings
 * Cookie policy
 * Privacy policy
 * Legal notice



Close

Close


THIS FEATURE IS AVAILABLE TO SUBSCRIBERS ONLY

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an
annual subscription.

Close




Manage Cookies

When you visit web sites, they may store or retrieve data in your web browser.
This storage is often necessary for basic functionality of the web site or the
storage may be used for the purposes of marketing, analytics, and
personalization of the web site such as storing your preferences.



Powered by Privado

Save

Oxford University Press uses cookies to enhance your experience on our website.
By selecting ‘accept all’ you are agreeing to our use of cookies. You can change
your cookie settings at any time. More information can be found in our Cookie
Policy.

Reject and manage Deny all Accept all